Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 166 AL 180

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease

Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J.

Molecules. 2022 Jun 29;27(13):4175. doi: 10.3390/molecules27134175.

The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia

Hickman SE, Mitchell SL, Hanson LC, Tu W, Stump TE, Unroe KT.

Clin Trials. 2022 Dec;19(6):623-635. doi: 10.1177/17407745221108992. Epub 2022 Jul 10.

Editorial: The dawn of a new era of Alzheimer's research and drug development

Hara Y, Fillit HM.

J Prev Alzheimers Dis. 2022;9(3):385-386. doi: 10.14283/jpad.2022.64.

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R.

J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50.

Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease

Gu L, Xu H, Qian F.

J Prev Alzheimers Dis. 2022;9(3):410-424. doi: 10.14283/jpad.2022.40.

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding

Ruiz A, Sánchez D, Lafuente A, Ortega G, Buendía M, Papasey J, Jimeno SY, Badia FP, Palacio ME, Abdelnour C, Ramírez-Toraño F, Maestú F, Sáez ME, Tárraga L, Dagnelie PC, Boada M.

J Prev Alzheimers Dis. 2022;9(3):425-434. doi: 10.14283/jpad.2022.38.

Nanoparticles-based anti-aging treatment of Alzheimer's disease

Chu JJ, Ji WB, Zhuang JH, Gong BF, Chen XH, Cheng WB, Liang WD, Li GR, Gao J, Yin Y.

Drug Deliv. 2022 Dec;29(1):2100-2116. doi: 10.1080/10717544.2022.2094501.

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease

Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z.

Eur J Med Chem. 2022 Oct 5;240:114606. doi: 10.1016/j.ejmech.2022.114606. Epub 2022 Jul 16.

A Review of African Medicinal Plants and Functional Foods for the Management of Alzheimer's Disease-related Phenotypes, Treatment of HSV-1 Infection and/or Improvement of Gut Microbiota

Tettevi EJ, Maina M, Simpong DL, Osei-Atweneboana MY, Ocloo A.

J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221114657. doi: 10.1177/2515690X221114657.

Pivotal role of nitrogen heterocycles in Alzheimer's disease drug discovery

Kumari S, Maddeboina K, Bachu RD, Boddu SHS, Trippier PC, Tiwari AK.

Drug Discov Today. 2022 Oct;27(10):103322. doi: 10.1016/j.drudis.2022.07.007. Epub 2022 Jul 19.

Adenosine receptor signalling in Alzheimer's disease

Trinh PNH, Baltos JA, Hellyer SD, May LT, Gregory KJ.

Purinergic Signal. 2022 Sep;18(3):359-381. doi: 10.1007/s11302-022-09883-1. Epub 2022 Jul 23.

Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways

Lipton SA.

Curr Opin Pharmacol. 2022 Oct;66:102267. doi: 10.1016/j.coph.2022.102267. Epub 2022 Jul 20.

Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews

Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S, Naseri A.

Eur J Clin Pharmacol. 2022 Oct;78(10):1567-1587. doi: 10.1007/s00228-022-03363-6. Epub 2022 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias